Key Takeaways Novavax reports a Q3 loss of 62 cents per share, narrower than the estimated loss of $1.08.Quarterly revenues of$70.4M beat estimates, aided by a $48M milestone payment from Sanofi.NVAX raised 2025 revenue view to$1.04-$1.06B and cut expense forecast amid cost reductions.Novavax (NVAX) incurred a loss of 62 cents per share in the third quarter of 2025, which was narrower than the Zacks Consensus Estimate of a loss of$1.08 per share. In the year-ago quarter, the company had recorded a loss o ...